What is Incyte's common stock?

Incyte (INCY) reported common stock of 400M in Q1 2026.

How has Incyte's common stock changed year-over-year?

Incyte's common stock decreased by 0.0% year-over-year, from 400M to 400M.

What is the long-term trend for Incyte's common stock?

Over 5 years (2020 to 2025), Incyte's common stock has grown at a 349.1% compound annual growth rate (CAGR), from 219K to 400M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Incyte INCY Common Stock

Common Stock at other companies

Bristol-Myers SquibbBMY

$292M0.0%

Celldex TherapeuticsCLDX

$67K+1.5%

GeronGERN

$641K+0.6%

Protagonist TherapeuticsPTGX

$1K0.0%

Syndax PharmaceuticalsSNDX

$9K0.0%

Agios PharmaceuticalsAGIO

$76K+2.7%

Other financials

Income statement

See full

Revenue$1.3B+20.9%

Gross profit$1.2B+19.2%

Operating income$301.1M+46.8%

Net income$303.3M+91.7%

EPS (diluted)$1.47+83.7%

Balance sheet

See full

Cash & equivalents$3.5B+78.2%

Total debt$39.4M-8.6%

Total equity$5.6B+53.3%

Total assets$7.3B+27.7%

Cash flow

See full

Operating cash flow$369.4M+38.8%

CapEx$1.6M-43.5%

Free cash flow$367.7M+39.7%

Valuation

See full

Market cap$23.31B+70.9%

Enterprise value$19.89B+69.6%

P/E16.3×+0.6×

P/S4.4×+1.4×

Profitability

See full

Gross margin92.5%-0.2pp

Operating margin30%+26.1pp

Net margin26.7%+26.2pp

FCF margin28.2%+19.7pp

Returns & leverage

See full

Return on equity30.8%+30.4pp

Debt / equity0×0.0×

Current ratio3.7×+1.6×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Incyte's common stock?: Incyte (INCY) reported common stock of 400M in Q1 2026.
How has Incyte's common stock changed year-over-year?: Incyte's common stock decreased by 0.0% year-over-year, from 400M to 400M.
What is the long-term trend for Incyte's common stock?: Over 5 years (2020 to 2025), Incyte's common stock has grown at a 349.1% compound annual growth rate (CAGR), from 219K to 400M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).